158 related articles for article (PubMed ID: 404372)
1. Immunochemical studies on the nature of the serum component (SAA) related to secondary amyloidosis.
Ignaczak TF; Sipe JD; Linke FP; Glenner GG
J Lab Clin Med; 1977 May; 89(5):1092-1104. PubMed ID: 404372
[TBL] [Abstract][Full Text] [Related]
2. Isolation and structural properties of murine SAA--the acute phase serum precursor of amyloid AA.
Sipe JD; McAdam KP; Torain BF; Pollock PS
Immunol Commun; 1977; 6(1):1-12. PubMed ID: 863470
[TBL] [Abstract][Full Text] [Related]
3. Amyloid fibril protein AA: purification and properties of the antigenically related serum component as determined by solid phase radioimmunoassay.
Sipe JD; Ignaczak TF; Pollock PS; Glenner GG
J Immunol; 1976 Apr; 116(4):1151-6. PubMed ID: 1254964
[TBL] [Abstract][Full Text] [Related]
4. Conformational flexibility of the serum amyloid precursor SAA.
Sipe JD; McAdam KP; Torain BF; Glenner GG
Br J Exp Pathol; 1976 Oct; 57(5):582-92. PubMed ID: 999792
[TBL] [Abstract][Full Text] [Related]
5. Serum amyloid A protein in amyloidosis, rheumatic, and enoplastic diseases.
Benson MD; Cohen AS
Arthritis Rheum; 1979 Jan; 22(1):36-42. PubMed ID: 103558
[TBL] [Abstract][Full Text] [Related]
6. Antigenic difference between serum amyloid protein SSA and its low molecular weight derivative SAAL revealed by an anti-amyloid A antiserum at different temperatures.
Linke RP
Z Immunitatsforsch Immunobiol; 1978 Mar; 154(2):169-72. PubMed ID: 77090
[TBL] [Abstract][Full Text] [Related]
7. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein.
Gillmore JD; Lovat LB; Persey MR; Pepys MB; Hawkins PN
Lancet; 2001 Jul; 358(9275):24-9. PubMed ID: 11454373
[TBL] [Abstract][Full Text] [Related]
8. Enzyme-linked immunosorbent assay of serum protein SAA in rhesus monkeys with secondary amyloidosis.
Doepel FM; Glorioso JC; Newcomer CE; Skinner M; Abrams GD
Lab Invest; 1981 Jul; 45(1):7-13. PubMed ID: 7253566
[TBL] [Abstract][Full Text] [Related]
9. Amyloid fibril protein AA in Papua New Guinean amyloidosis.
Anders RF; Price MA; Wilkey IS; Husby G; Takitaki F; Natvig JB; McAdam KP
Clin Exp Immunol; 1976 Apr; 24(1):49-53. PubMed ID: 820500
[TBL] [Abstract][Full Text] [Related]
10. The value of the levels of acute phase reactants for the prediction of familial Mediterranean fever associated amyloidosis: a case control study.
Yalçinkaya F; Cakar N; Acar B; Tutar E; Güriz H; Elhan AH; Oztürk S; Kansu A; Ince E; Atalay S; Girgin N; Doğru U; Aysev D; Ekim M
Rheumatol Int; 2007 Apr; 27(6):517-22. PubMed ID: 17103173
[TBL] [Abstract][Full Text] [Related]
11. Characterization of amyloid proteins AA and SAA as apolipoproteins of high density lipoprotein (HDL). Displacement of SAA from the HDL-SAA complex by apo AI and apo AII.
Husebekk A; Skogen B; Husby G
Scand J Immunol; 1987 Apr; 25(4):375-81. PubMed ID: 3107118
[TBL] [Abstract][Full Text] [Related]
12. Isolation of a low-molecular-weight serum component antigenically related to an amyloid fibril protein of unknown origin.
Linke RP; Sipe JD; Pollock PS; Ignaczak TF; Glenner GG
Proc Natl Acad Sci U S A; 1975 Apr; 72(4):1473-6. PubMed ID: 805429
[TBL] [Abstract][Full Text] [Related]
13. Amyloid-related serum protein (SAA) in patients with inherited amyloidosis and certain viral conditions.
Meretoja J; Natvig JB; Husby G
Scand J Immunol; 1976; 5(1-2):169-74. PubMed ID: 1083557
[TBL] [Abstract][Full Text] [Related]
14. Murine model for human secondary amyloidosis: genetic variability of the acute-phase serum protein SAA response to endotoxins and casein.
McAdam KP; Sipe JD
J Exp Med; 1976 Oct; 144(4):1121-7. PubMed ID: 978136
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of different amyloid fibril proteins in tissue sections.
Cornwell GG; Husby G; Westermark P; Natvig JB; Michaelsen TE; Skogen B
Scand J Immunol; 1977; 6(11):1071-80. PubMed ID: 413186
[TBL] [Abstract][Full Text] [Related]
16. Increased circulating serum amyloid A protein derivatives in rheumatoid arthritis patients with secondary amyloidosis.
Migita K; Eguchi K; Tsukada T; Kawabe Y; Takashima H; Mine M; Aoyagi T; Ichinose Y; Nagataki S
Lab Invest; 1996 Sep; 75(3):371-5. PubMed ID: 8804360
[TBL] [Abstract][Full Text] [Related]
17. Levels of the serum amyloid A protein (SAA) in normal persons of different age groups.
Hijmans W; Sipe JD
Clin Exp Immunol; 1979 Jan; 35(1):96-100. PubMed ID: 428149
[TBL] [Abstract][Full Text] [Related]
18. Natural history and outcome in systemic AA amyloidosis.
Lachmann HJ; Goodman HJ; Gilbertson JA; Gallimore JR; Sabin CA; Gillmore JD; Hawkins PN
N Engl J Med; 2007 Jun; 356(23):2361-71. PubMed ID: 17554117
[TBL] [Abstract][Full Text] [Related]
19. Three assays for the characterization and quantitation of human serum amyloid A.
Marhaug G
Scand J Immunol; 1983 Oct; 18(4):329-38. PubMed ID: 6417768
[TBL] [Abstract][Full Text] [Related]
20. Amyloid fibril protein subunit, "protein AS": distribution in tissue and serum in different clinical types of amyloidosis including that associated with myelomatosis and Waldenström's macroglobulinamia.
Husby G; Sletten K; Michaelsen TE; Natvig JB
Scand J Immunol; 1973; 2(4):395-404. PubMed ID: 4203674
[No Abstract] [Full Text] [Related]
[Next] [New Search]
